Funds

Parkwalk is the largest growth EIS fund manager, backing world changing technologies from the UK’s leading universities.

Do not invest unless you are prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Flagship EIS Funds

Opportunities EIS Fund

This Fund invests in a portfolio of early stage, high-growth companies spun out from UK universities across a diverse portfolio of sectors and maturities. Sectors include Quantum Computing, AI, MedTech, Life Sciences, CleanTech and more.
Portfolio size
8 companies
Stage
Series A-C
Reliefs
EIS tax reliefs available
Find out more

Knowledge Intensive EIS Fund V

The KI Funds mirror the investment strategy of the Opportunities EIS Fund, investing in high-growth companies spun out from UK universities. The Fund facilitates income tax relief for 2025/26 or carry back to 2024/25.
Portfolio size
10+ companies
Close date
2nd April 2025
Reliefs
One EIS5 certificate
Find out more

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.